Nevro Corp. Files Proxy Statement Supplement
| Field | Detail |
|---|---|
| Company | Nevro Corp |
| Form Type | DEFA14A |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, supplement, shareholder-meeting
Related Tickers: NVRO
TL;DR
Nevro Corp. dropped more proxy docs. Standard shareholder stuff.
AI Summary
Nevro Corp. filed a supplement to its Definitive Proxy Statement on March 24, 2025, regarding its annual meeting of stockholders. The supplement provides additional materials related to the proxy statement previously filed on March 10, 2025. No specific proposals or voting matters are detailed in this supplement.
Why It Matters
This filing indicates Nevro Corp. is providing updated or additional information to shareholders before their annual meeting, which is a standard part of corporate governance and shareholder communication.
Risk Assessment
Risk Level: low — This is a routine administrative filing supplementing a previous proxy statement, with no new material proposals or significant financial changes disclosed.
Key Players & Entities
- NEVRO CORP (company) — Registrant
- 0001193125-25-060933 (filing_id) — Accession Number
- March 10, 2025 (date) — Date of original Definitive Proxy Statement
- March 24, 2025 (date) — Filing date of the supplement
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Supplement to the Definitive Proxy Statement of Nevro Corp., filed on March 24, 2025, providing additional materials related to the proxy statement previously filed on March 10, 2025.
When was the original Definitive Proxy Statement filed?
The original Definitive Proxy Statement was filed on March 10, 2025.
What is the filing date of this Supplement?
This Supplement was filed on March 24, 2025.
Is this a preliminary or definitive proxy statement?
This filing is marked as 'Definitive Additional Materials', supplementing a previously filed Definitive Proxy Statement.
Who is the filer?
The filer is Nevro Corp., as indicated by 'Filed by the Registrant'.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 24, 2025 regarding NEVRO CORP.